|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.775 USD | +2.01% |
|
0.00% | +29.20% |
| Market Cap | 601M 528M 491M 451M 848M 57.59B 859M 5.84B 2.28B 28.44B 2.25B 2.21B 98.29B | P/E 2026 * |
-2.45x | P/E 2027 * | -2.28x |
|---|---|---|---|---|---|
| Enterprise Value | 415M 365M 340M 312M 585M 39.79B 593M 4.04B 1.58B 19.65B 1.56B 1.52B 67.9B | EV / Sales 2026 * |
62,202x | EV / Sales 2027 * | 34.2x |
| Free-Float |
83.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | +2.01% | ||
| Current month | -14.90% | ||
| 1 month | -20.27% | ||
| 3 months | -21.33% | ||
| 6 months | +15.69% | ||
| Current year | +29.20% |
| 1 week | 1.74 |  | 1.91 |
| 1 month | 1.74 | | 2.25 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
David Chang
BRD | Director/Board Member | 66 | 01/06/2018 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/7/26 | Free | Chief Executive Officer | 610,720 | 0.1769% | ||
| 18/6/26 | Free | Director | 95,400 | 0.0276% | ||
| 18/6/26 | Fiscal year | Founder | 190,800 | 0.0553% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.01% | 0.00% | +20.41% | -62.58% | 601M | |
| -1.82% | +4.80% | +54.32% | +68.36% | 57.28B | |
| -0.27% | +5.74% | +40.26% | +80.17% | 54.99B | |
| -1.52% | -1.51% | +3.59% | +416.69% | 23.18B | |
| +2.80% | -0.35% | -18.57% | -12.53% | 22.59B | |
| -1.13% | +4.54% | +22.73% | -8.06% | 20.46B | |
| +1.57% | +3.30% | +27.41% | -29.07% | 17.56B | |
| -0.10% | +5.57% | +38.63% | +565.16% | 15.67B | |
| +5.29% | 0.00% | +185.09% | +332.66% | 14.46B | |
| +1.16% | +1.09% | +26.46% | +186.40% | 13.92B | |
| Average | +0.79% | +1.17% | +40.03% | +153.72% | 24.07B | |
| Weighted average by Cap. | +0.01% | +1.92% | +39.87% | +138.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.67K 5.86K 5.46K 5.01K 9.41K 640K 9.54K 64.88K 25.34K 316K 25.04K 24.5K 1.09M | 14.59M 12.83M 11.94M 10.97M 20.6M 1.4B 20.87M 142M 55.45M 691M 54.79M 53.61M 2.39B |
| Net income | -197M -173M -161M -148M -278M -18.93B -282M -1.92B -750M -9.35B -741M -725M -32.3B | -231M -203M -189M -174M -326M -22.16B -330M -2.25B -878M -10.94B -867M -849M -37.82B |
| Net Debt | -186M -163M -152M -140M -262M -17.81B -265M -1.81B -705M -8.79B -697M -682M -30.39B | -101M -88.61M -82.48M -75.75M -142M -9.67B -144M -980M -383M -4.77B -378M -370M -16.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | US$1.775 | +2.01% | 4,290,691 |
| 24/07/26 | US$1.740 | -4.40% | 4,874,170 |
| 23/07/26 | US$1.820 | -2.15% | 5,640,284 |
| 22/07/26 | US$1.860 | +0.54% | 4,135,068 |
| 21/07/26 | US$1.850 | +4.52% | 4,490,116 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
